v3.26.1
Condensed Consolidated Interim Statements of Shareholders' Equity (unaudited) - USD ($)
$ in Thousands
Total
Common stock
Other equity instruments
Additional paid in capital
Accumulated deficit
Accumulated other comprehensive loss
Balance (in shares) at Dec. 31, 2024   17,282,934        
Balance at Dec. 31, 2024 $ 137,025 $ 1,245,805 $ 9,472 $ 11,516 $ (1,096,275) $ (33,493)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common shares on exercise of share units (in shares)   43,798        
Issuance of common shares on exercise of share units 0 $ 603 (603)      
Stock-based compensation 212   212      
Net loss for the period (2,451)       (2,451)  
Other comprehensive income (loss) 2,812         2,812
Balance (in shares) at Mar. 31, 2025   17,326,732        
Balance at Mar. 31, 2025 $ 137,598 $ 1,246,408 9,081 11,516 (1,098,726) (30,681)
Balance (in shares) at Dec. 31, 2025 17,351,005 17,375,213        
Balance at Dec. 31, 2025 $ 68,813 $ 1,246,793 8,968 11,516 (1,157,901) (40,563)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common shares on exercise of share units (in shares)   20,521        
Issuance of common shares on exercise of share units 0 $ 266 (266)      
Stock-based compensation 86   86      
Net loss for the period (5,707)       (5,707)  
Other comprehensive income (loss) $ (308)         (308)
Balance (in shares) at Mar. 31, 2026 17,395,734 17,395,734        
Balance at Mar. 31, 2026 $ 62,884 $ 1,247,059 $ 8,788 $ 11,516 $ (1,163,608) $ (40,871)